TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36423400

Group type: EXPERIMENTAL
Intervention: Exercise&Education
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control (CPC)
Number of subjects: 163
Study: 34127092

Group type: EXPERIMENTAL
Intervention: Lumateperone 42mg
Number of subjects: 256

Group type: COMPARATOR
Intervention: Risperidone 4mg
Number of subjects: 256
Study: 32013530

Group type: EXPERIMENTAL
Intervention: T'ai Chi (TC)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 57
Study: 35617296

Group type: EXPERIMENTAL
Intervention: Asymptomatic malaria parasitaemia
Number of subjects: 1587

Group type: EXPERIMENTAL
Intervention: Not sleeping under a bednet
Number of subjects: 1587

Group type: EXPERIMENTAL
Intervention: Illiterate parent or guardian
Number of subjects: 1587

Group type: EXPERIMENTAL
Intervention: History of malaria in the past one month
Number of subjects: 1587

Group type: EXPERIMENTAL
Intervention: Stunted children
Number of subjects: 1587
Study: 34127045

Group type: EXPERIMENTAL
Intervention: Ca-polyP graft material only
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ca-polyP in combination with biphasic calcium phosphate (BCP)
Number of subjects: 8
Study: 32677930

Group type: EXPERIMENTAL
Intervention: Parent-child communication about sexual issues (perceived comfort in communication)
Number of subjects: 4343

Group type: EXPERIMENTAL
Intervention: Parent-child communication about sexual issues (parental connection)
Number of subjects: 4343

Group type: EXPERIMENTAL
Intervention: Parent-child communication about sexual issues (fear-based communication)
Number of subjects: 4343

Group type: EXPERIMENTAL
Intervention: Parent-child communication about sexual issues (opposition to contraception education)
Number of subjects: 4343

Group type: EXPERIMENTAL
Intervention: Parent-child communication about sexual issues (school enrollment status)
Number of subjects: 4343
Study: 34850164

Group type: EXPERIMENTAL
Intervention: eGo-style ENDS with 36 mg/ml nicotine liquid
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: eGo-style ENDS with 0 mg/ml nicotine liquid
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: eGo-style ENDS with 8 mg/ml nicotine liquid
Number of subjects: 520

Group type: COMPARATOR
Intervention: Cigarette substitute (CS)
Number of subjects: 520
Study: 35486921

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided axillary brachial plexus block
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (standard analgesia)
Number of subjects: 20
Study: 33345388

Group type: EXPERIMENTAL
Intervention: Premium hearing aids (A)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Basic hearing aids (B)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No amplification (C)
Number of subjects: 22
Study: 34969263

Group type: EXPERIMENTAL
Intervention: One-Shot Dilatation (OSD) using a single Amplatz dilator (30F)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Metal Telescopic Dilator (MTD) using sequential MTD (9-30F)
Number of subjects: 150
Study: 32193622

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 94

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 94
Study: 36071530

Group type: EXPERIMENTAL
Intervention: Multi-component intervention including Menstrual Health Action Group, NGO-led training, drama skit, menstrual health kit (reusable pads and menstrual cups), pain management strategies, and improvements to school facilities.
Number of subjects: 3600
Study: 32323166

Group type: EXPERIMENTAL
Intervention: Getting To Outcomes (GTO) implementation support intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 29
Study: 35470551

Group type: EXPERIMENTAL
Intervention: Amphetamine (AMPH) 30 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32456807

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35937386

Group type: EXPERIMENTAL
Intervention: Microneedle injection of MEBO combined with blood transfusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moist exposed burn ointment (MEBO) combined with blood transfusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcipotriol ointment external application
Number of subjects: 60
Study: 34167872

Group type: EXPERIMENTAL
Intervention: Metformin plus standard of care
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 124
Study: 32119816

Group type: EXPERIMENTAL
Intervention: Sound enrichment procedures for 2 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no sound enrichment)
Number of subjects: 19
Study: 34256536

Group type: EXPERIMENTAL
Intervention: Core muscle strengthening exercise protocol for six weeks, 3 days a week.
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no exercise program, continued usual cricket training).
Number of subjects: 98
Study: 34018333

Group type: EXPERIMENTAL
Intervention: Anodal vmPFC tDCS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Anodal r-TPJ tDCS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 16
Study: 34110742

Group type: EXPERIMENTAL
Intervention: EMPWR intervention
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control
Number of subjects: 301
Study: 34027853

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 34793376

Group type: EXPERIMENTAL
Intervention: Every-other-day fasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35713267

Group type: EXPERIMENTAL
Intervention: IIP+CTG
Number of subjects: 30
Study: 32788001

Group type: EXPERIMENTAL
Intervention: Irradiated teeth (exposed to radiation at a dose fraction of two Gy for five consecutive days until reaching a total dose of 60 Gy)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonirradiated teeth
Number of subjects: 12
Study: 33745460

Group type: EXPERIMENTAL
Intervention: Legume-enriched diet (LD) group
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual diet (UD) group
Number of subjects: 400
Study: 35487422

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subcostal TAP block (USTAP)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Laparoscopic subcostal TAP block (LSTAP)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no TAP block)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: USTAP and LSTAP
Number of subjects: 110
Study: 35578213

Group type: EXPERIMENTAL
Intervention: Healthy Working Approach intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 200
Study: 34714252

Group type: EXPERIMENTAL
Intervention: Self-directed digitally delivered intervention (web-based education, exercise, and physical activity program supported by automated exercise behavior change mobile phone text messages)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (web-based education alone)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Self-directed digitally delivered intervention
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 206
Study: 33792451

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) prescribed to patients with SVC decline; compliance recorded as used ≥2 h/24 h.
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) prescribed to patients with SVC decline; compliance recorded as used ≥4 h/24 h.
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) prescribed to patients with SVC decline; compliance recorded as used ≥22 h/24 h.
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) prescribed to patients with SVC decline; reasons for prescription.
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) prescribed to patients with SVC decline; follow-up of patients with SVC below 50%.
Number of subjects: 565
Study: 33331406

Group type: EXPERIMENTAL
Intervention: 12-month follow-up interval (Group 1)
Number of subjects: 224

Group type: COMPARATOR
Intervention: 18-month follow-up interval (Group 2)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Both follow-up intervals
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Higher number of teeth with initial active lesions
Number of subjects: 224
Study: 33446872

Group type: EXPERIMENTAL
Intervention: Prenatal ultrasound
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 130
Study: 32474710

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block
Number of subjects: 49
Study: 36350098

Group type: EXPERIMENTAL
Intervention: SuperPATH approach
Number of subjects: 101

Group type: COMPARATOR
Intervention: Posterior approach
Number of subjects: 101
Study: 35605013

Group type: EXPERIMENTAL
Intervention: 10 mg daily oral tamoxifen
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 20 mg daily oral tamoxifen
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 33403822

Group type: EXPERIMENTAL
Intervention: 2-year multi-domain lifestyle intervention
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1207
Study: 35343332

Group type: EXPERIMENTAL
Intervention: Contrast with compression (CwC) therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: No therapy (control)
Number of subjects: 10
Study: 32914483

Group type: EXPERIMENTAL
Intervention: Black barberry extract (1,000 mg, two capsules daily for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Maltodextrin placebo (two capsules daily for 12 weeks)
Number of subjects: 80
Study: 35730943

Group type: EXPERIMENTAL
Intervention: Portable HEPA filter air cleaners used from a median of 11 weeks gestation until the end of pregnancy
Number of subjects: 540

Group type: COMPARATOR
Intervention: No air cleaners (control group)
Number of subjects: 540
Study: 32394103

Group type: EXPERIMENTAL
Intervention: AI-guided PVI
Number of subjects: 226

Group type: COMPARATOR
Intervention: CF-guided PVI
Number of subjects: 226
Study: 35895150

Group type: EXPERIMENTAL
Intervention: Khanya intervention (cognitive-behavioral therapy-based)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 61
Study: 33471853

Group type: EXPERIMENTAL
Intervention: Haematological parameters (RBC, Hb, HCT, MCV, PLT, WBC)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Biochemical analytes (Urea, Cr, Trig, HDL-C, AST, ALT, ALP, GGT, BID, BIT, Prot-T, Albumin)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Comparison of RIs with analyzers and those from other countries
Number of subjects: 1227
Study: 32936895

Group type: EXPERIMENTAL
Intervention: Physiological age-grading system based on ovarian morphology
Number of subjects: 0
Study: 32294316

Group type: EXPERIMENTAL
Intervention: Successful CTO PCI (SPCI)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Failed PCI (FPCI)
Number of subjects: 302

Group type: COMPARATOR
Intervention: No-CTO PCI (NPCI)
Number of subjects: 302
Study: 32132506

Group type: EXPERIMENTAL
Intervention: Pancreaticoduodenectomy in PHC group
Number of subjects: 170

Group type: COMPARATOR
Intervention: Pancreaticoduodenectomy in non-PHC group
Number of subjects: 170
Study: 36191734

Group type: EXPERIMENTAL
Intervention: 10-minute instant meditation practice using a mobile app (Group A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 10-day app-based mindfulness meditation (Group B)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No intervention (Group C)
Number of subjects: 43
Study: 34213861

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 295

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 295
Study: 32998708

Group type: EXPERIMENTAL
Intervention: Mindfetalness
Number of subjects: 26485
Study: 36302965

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (16 IU, administered morning and night for 12 weeks)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo nasal spray (administered morning and night for 12 weeks)
Number of subjects: 87
Study: 33164114

Group type: EXPERIMENTAL
Intervention: RIRS single-use ureteroscope
Number of subjects: 158

Group type: COMPARATOR
Intervention: ESWL
Number of subjects: 158
Study: 32052341

Group type: EXPERIMENTAL
Intervention: Bevacizumab with chemotherapy
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Aflibercept with chemotherapy
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Bevacizumab followed by aflibercept
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: First-line bevacizumab
Number of subjects: 366
Study: 36121843

Group type: EXPERIMENTAL
Intervention: Fibersol-2 low dose (2.5g)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fibersol-2 high dose (5g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diarrheal children
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diarrheal and healthy children
Number of subjects: 60
Study: 34342032

Group type: EXPERIMENTAL
Intervention: MVMR‐Robust
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MVMR‐Lasso
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MVMR‐Median
Number of subjects: 0
Study: 32545112

Group type: EXPERIMENTAL
Intervention: Cork fish extract (Pujimin Plus)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no cork fish extract)
Number of subjects: 34
Study: 34643960

Group type: EXPERIMENTAL
Intervention: CHRT-SR7
Number of subjects: 788
Study: 34518158

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 102

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 102
Study: 32912616

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study: 36181505

Group type: EXPERIMENTAL
Intervention: Clinical-radiological model based on peak enhancement phase, tumor location, alpha-fetoprotein, cancer antigen (CA)-125, CA724 levels, CT-based Tstage, and arterial phase CT values.
Number of subjects: 461
Study: 33185112

Group type: EXPERIMENTAL
Intervention: Simulated binge drinking (4-5 drink equivalent in <2 h)
Number of subjects: 22
Study: 36336989

Group type: COMPARATOR
Intervention: Hydroxypropyl chitosan-based 80 mg/g ciclopirox nail lacquer
Number of subjects: 381
Study: 33743622

Group type: EXPERIMENTAL
Intervention: Yoga intervention (initial five-day structured training and home practice for 90 days)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Wait-list control (no yoga intervention)
Number of subjects: 121
Study: 35946753

Group type: EXPERIMENTAL
Intervention: Energy Drink (ED) protocol
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo protocol (250 mL of water)
Number of subjects: 28
Study: 33844373

Group type: EXPERIMENTAL
Intervention: Erythritol air polishing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Piezoelectric ultrasonic scaling
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 34766590

Group type: EXPERIMENTAL
Intervention: APOL1 risk alleles (2 alleles)
Number of subjects: 11930

Group type: EXPERIMENTAL
Intervention: APOL1 risk alleles (1 allele)
Number of subjects: 11930

Group type: EXPERIMENTAL
Intervention: APOL1 risk alleles (per allele)
Number of subjects: 11930
Study: 36314965

Group type: EXPERIMENTAL
Intervention: Audibility-based descriptions
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Simulation-based descriptions
Number of subjects: 143

Group type: COMPARATOR
Intervention: Classification-based descriptions
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Audibility-based and simulation-based groups
Number of subjects: 143
Study: 34397596

Group type: EXPERIMENTAL
Intervention: Sequential Feeding (SF)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Continuous Feeding (CF)
Number of subjects: 62
Study: 33123089

Group type: EXPERIMENTAL
Intervention: Shared Medical Appointments with mindfulness (six 2‐h programmed SMAs held fortnightly)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care from healthcare providers
Number of subjects: 18
Study: 35619802

Group type: EXPERIMENTAL
Intervention: Integrated multidisciplinary program for managing TB and DM
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Non-physician health workers training
Number of subjects: 120
Study: 33629490

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels of 70–89 g/l at 6+0–13+6 weeks
Number of subjects: 11976

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 26–30 weeks of gestation
Number of subjects: 11976

Group type: COMPARATOR
Intervention: Haemoglobin levels of 110–129 g/l at 6+0–13+6 weeks
Number of subjects: 11976

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 6+0–13+6 weeks and 26–30 weeks
Number of subjects: 11976
Study: 32426888

Group type: EXPERIMENTAL
Intervention: Physically active instruction (20 minutes, 38% heart rate reserve)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional sedentary instruction (21% heart rate reserve)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Physically active instruction
Number of subjects: 51
Study: 35421865

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: M‐SE score
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: M‐SE stages
Number of subjects: 209
Study: 35988513

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 33197076

Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic impact on gastrointestinal symptoms
Number of subjects: 5157

Group type: EXPERIMENTAL
Intervention: FD-IBS overlap syndrome
Number of subjects: 5157

Group type: EXPERIMENTAL
Intervention: Psychological disease comorbidity and stress at work/school
Number of subjects: 5157

Group type: EXPERIMENTAL
Intervention: Younger age, commuting by public transport, work/study from home
Number of subjects: 5157
Study: 35168560

Group type: EXPERIMENTAL
Intervention: Surgery followed by 6 months of oral uracil and tegafur plus leucovorin (UFT/LV)
Number of subjects: 1902

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1902
Study: 34886299

Group type: EXPERIMENTAL
Intervention: Pethidine (50 mg intravenously)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Entonox® (50% nitrous oxide)
Number of subjects: 136
Study: 32553875

Group type: EXPERIMENTAL
Intervention: Dynamic Navigation System (DNS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual Approach (MA)
Number of subjects: 20
Study: 35260735

Group type: EXPERIMENTAL
Intervention: Cervical immobilization using a cervical collar (collar group)
Number of subjects: 170

Group type: COMPARATOR
Intervention: No cervical immobilization (control group)
Number of subjects: 170
Study: 33148311

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) integrated into computerized physician order entry (CPOE)
Number of subjects: 280
Study: 33922546

Group type: EXPERIMENTAL
Intervention: Sodium glucose cotransporter 2 inhibitors (SGLT2i)
Number of subjects: 0
Study: 34477120

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control
Number of subjects: 128
Study: 35715681

Group type: EXPERIMENTAL
Intervention: Single dose of Macrogol-based solution the day prior to examination (Regimen A)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Fractionated dose of Macrogol-based solution 2 days before examination (Regimen B)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Fractionated dose of Macrogol-based solution 3 days before examination (Regimen C)
Number of subjects: 180
Study: 37653386

Group type: EXPERIMENTAL
Intervention: Environmental intervention (E)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Individual intervention (I)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Environmental plus individual intervention (E+I)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Assessment only control group (C)
Number of subjects: 600
Study: 34242311

Group type: EXPERIMENTAL
Intervention: Soil organic carbon (SOC) content and its distribution in water-stable aggregates (WAS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physical fractionation by size-density of macroorganic matter into light (LF), intermediate (IF), and heavy (HF) fractions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High yields associated with high C content in stable aggregates
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Use of organic fertilizers less recalcitrant
Number of subjects: 12
Study: 36260533

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Feeding alone
Number of subjects: 8
Study: 33871616

Group type: EXPERIMENTAL
Intervention: Oral ondansetron
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Intravenous rehydration
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Hospitalization
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Clinical Dehydration Scale score (mild to moderate vs none)
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Clinical Dehydration Scale score (severe vs none)
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Country (US vs Canada)
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Prior health care visit with intravenous fluids
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Frequency of vomiting (per 5 episodes)
Number of subjects: 1846
Study: 36370589

Group type: EXPERIMENTAL
Intervention: Monitoring with a respiratory volume monitor from admission to PACU until the earlier of 48 h after surgery or discharge
Number of subjects: 292
Study: 33579615

Group type: EXPERIMENTAL
Intervention: Neurofeedback (sensorimotor and alpha rhythm feedback for 8 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Telephone support (control group, N = 20)
Number of subjects: 80
Study: 32496074

Group type: EXPERIMENTAL
Intervention: Pandemic/lockdown group
Number of subjects: 2006

Group type: COMPARATOR
Intervention: Prelockdown prepandemic group
Number of subjects: 2006
Study: 35287511

Group type: EXPERIMENTAL
Intervention: T1D Financial Toolkit (online financial and health insurance education toolkit)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 39
Study: 32418845

Group type: COMPARATOR
Intervention: Sham treatment (control group)
Number of subjects: 141